-
PurposeLuciferase Reporter for mutant STAT3
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 46933 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepTAL-Luc
-
Backbone manufacturerClontech
- Backbone size w/o insert (bp) 5000
- Total vector size (bp) 2351
-
Vector typeLuciferase
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameSTAT3(Y705F)
-
Alt nameSTAT3
-
Alt namesignal transducer and activator of transcription 3 (acute-phase response factor)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2351
-
MutationTyrosine 705 to Phenylalanine
-
Entrez GeneSTAT3 (a.k.a. ADMIO, ADMIO1, APRF, HIES)
- Promoter TA Luciferase
-
Tag
/ Fusion Protein
- FLAG (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer 5'-CGGGAGGTACTTGGAGCG-3' (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byGeorge Stark Lab, Case Western Reserve University
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
STAT3(Y705F)-TAL-Luc was a gift from Afshin Dowlati (Addgene plasmid # 46933 ; http://n2t.net/addgene:46933 ; RRID:Addgene_46933) -
For your References section:
The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent. Dabir S, Kluge A, Dowlati A. Mol Cancer Res. 2009 Nov;7(11):1854-60. doi: 10.1158/1541-7786.MCR-09-0313. Epub 2009 Nov 10. 10.1158/1541-7786.MCR-09-0313 PubMed 19903771